Every SEC Form 3/4/5 on record for this filer (CIK 1898677) — 7 issuers, 18 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
1 filing failed a price guard — listed below with the reason, excluded from the totals above.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS, INC. /DE/ | 10% owner | 2023-02-08 → 2025-10-17 | 4 | $4M |
| COLL | COLLEGIUM PHARMACEUTICAL, INC | 10% owner | 2025-08-15 → 2025-08-15 | 2 | — |
| TLN | Talen Energy Corp | 10% owner | 2024-07-09 → 2025-06-27 | 3 | −$1000M |
| MREO | Mereo BioPharma Group plc | 10% owner · lapsed | 2024-01-02 → 2024-06-17 | 2 | — |
| TXMD | TherapeuticsMD, Inc. | 10% owner · lapsed | 2022-07-19 → 2023-11-17 | 11 | $3M |
| RDUS | Radius Health, Inc. | 10% owner · lapsed | 2021-12-10 → 2022-08-12 | 5 | $15M |
| VINC | Vincerx Pharma, Inc. | 10% owner · lapsed | 2022-01-31 → 2022-01-31 | 1 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| HRTX | 2025-08-08 | Buy | 2,387,225 | $1.50 | $4M | 29,100,728 |
| TLN | 2024-12-13 | Sell | 4,893,507 | $204.35 | $1000M | 6,475,107 |
| TXMD | 2022-12-08 | Buy | 300 | $5.83 | $1,749 | 1,742,366 |
| TXMD | 2022-12-07 | Buy | 20,113 | $5.66 | $113,840 | 1,742,066 |
| TXMD | 2022-07-29 | Buy | 565,000 | $4.72 | $3M | 1,721,953 |
| TXMD | 2022-07-29 | Buy | 15,000 | $822.21 | $12M | 15,000 |
| ⚠ excluded from the dollar totals — reported price $822.21 is more than 50x away from TXMD's own median open-market price ($4.78) — a fat-finger | ||||||
5 of 7 issuers are covered and open a security page; the rest are on file here only.
